Nathalie M. Fiaschi-Taesch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathalie M. Fiaschi-Taesch has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Andrew F. Stewart
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
3 shared publicationsKaren K. Takane
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
3 shared publicationsAmy E. Cox
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 shared publicationsDonald K. Scott
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 shared publicationsFatimah G. Salim
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 shared publicationsGabriella Casinelli
Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 shared publications
Latest Publications
- Open Access
- 14 June 2013
- Published by American Diabetes Association in Diabetes
- Vol. 62 (7) , 2460-2470
Cytoplasmic-Nuclear Trafficking of G1/S Cell Cycle Molecules and Adult Human β-Cell Replication
Harnessing control of human β-cell proliferation has proven frustratingly difficult. Most G1/S control molecules, generally presumed to be nuclear proteins in the human β-cell, are in fact constrained to the cytoplasm. Here, we asked whether G1/S molecules might traffic into and out of the cytoplasmic compartment in association with activation of cell cycle progression. Cdk6 and cyclin D3 were used to drive human β-cell proliferation and promptly translocated into the nucleus in association with proliferation. In contrast, the cell cycle inhibitors p15, p18, and p19 did not alter their location, remaining cytoplasmic. Conversely, p16, p21, and p27 increased their nuclear frequency. In contrast once again, p57 decreased its nuclear frequency. Whereas proliferating β-cells contained nuclear cyclin D3 and cdk6, proliferation generally did not occur in β-cells that contained nuclear cell cycle inhibitors, except p21. Dynamic cytoplasmic-nuclear trafficking of cdk6 was confirmed using green fluorescent protein–tagged cdk6 and live cell imaging. Thus, we provide novel working models describing the control of cell cycle progression in the human β-cell. In addition to known obstacles to β-cell proliferation, cytoplasmic-to-nuclear trafficking of G1/S molecules may represent an obstacle as well as a therapeutic opportunity for human β-cell expansion.
- 14 June 2013
- Published by American Diabetes Association in Diabetes
- Vol. 62 (7) , 2460-2470
Open AccessCytoplasmic-Nuclear Trafficking of G1/S Cell Cycle Molecules and Adult Human β-Cell Replication
Harnessing control of human β-cell proliferation has proven frustratingly difficult. Most G1/S control molecules, generally presumed to be nuclear proteins in the human β-cell, are in fact constrained to the cytoplasm. Here, we asked whether G1/S molecules might traffic into and out of the cytoplasmic compartment in association with activation of cell cycle progression. Cdk6 and cyclin D3 were used to drive human β-cell proliferation and promptly translocated into the nucleus in association with proliferation. In contrast, the cell cycle inhibitors p15, p18, and p19 did not alter their location, remaining cytoplasmic. Conversely, p16, p21, and p27 increased their nuclear frequency. In contrast once again, p57 decreased its nuclear frequency. Whereas proliferating β-cells contained nuclear cyclin D3 and cdk6, proliferation generally did not occur in β-cells that contained nuclear cell cycle inhibitors, except p21. Dynamic cytoplasmic-nuclear trafficking of cdk6 was confirmed using green fluorescent protein–tagged cdk6 and live cell imaging. Thus, we provide novel working models describing the control of cell cycle progression in the human β-cell. In addition to known obstacles to β-cell proliferation, cytoplasmic-to-nuclear trafficking of G1/S molecules may represent an obstacle as well as a therapeutic opportunity for human β-cell expansion.
- Open Access
- 14 June 2013
- Published by American Diabetes Association in Diabetes
- Vol. 62 (7) , 2450-2459
Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas
Expansion of pancreatic β-cells is a key goal of diabetes research, yet induction of adult human β-cell replication has proven frustratingly difficult. In part, this reflects a lack of understanding of cell cycle control in the human β-cell. Here, we provide a comprehensive immunocytochemical “atlas” of G1/S control molecules in the human β-cell. This atlas reveals that the majority of these molecules, previously known to be present in islets, are actually present in the β-cell. More importantly, and in contrast to anticipated results, the human β-cell G1/S atlas reveals that almost all of the critical G1/S cell cycle control molecules are located in the cytoplasm of the quiescent human β-cell. Indeed, the only nuclear G1/S molecules are the cell cycle inhibitors, pRb, p57, and variably, p21: none of the cyclins or cdks necessary to drive human β-cell proliferation are present in the nuclear compartment. This observation may provide an explanation for the refractoriness of human β-cells to proliferation. Thus, in addition to known obstacles to human β-cell proliferation, restriction of G1/S molecules to the cytoplasm of the human β-cell represents an unanticipated obstacle to therapeutic human β-cell expansion.
- 14 June 2013
- Published by American Diabetes Association in Diabetes
- Vol. 62 (7) , 2450-2459
Open AccessHuman Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas
Expansion of pancreatic β-cells is a key goal of diabetes research, yet induction of adult human β-cell replication has proven frustratingly difficult. In part, this reflects a lack of understanding of cell cycle control in the human β-cell. Here, we provide a comprehensive immunocytochemical “atlas” of G1/S control molecules in the human β-cell. This atlas reveals that the majority of these molecules, previously known to be present in islets, are actually present in the β-cell. More importantly, and in contrast to anticipated results, the human β-cell G1/S atlas reveals that almost all of the critical G1/S cell cycle control molecules are located in the cytoplasm of the quiescent human β-cell. Indeed, the only nuclear G1/S molecules are the cell cycle inhibitors, pRb, p57, and variably, p21: none of the cyclins or cdks necessary to drive human β-cell proliferation are present in the nuclear compartment. This observation may provide an explanation for the refractoriness of human β-cells to proliferation. Thus, in addition to known obstacles to human β-cell proliferation, restriction of G1/S molecules to the cytoplasm of the human β-cell represents an unanticipated obstacle to therapeutic human β-cell expansion.
- 30 October 2009
- Published by Springer Nature
- p. 85-103
Cell Cycle Regulation in Human Pancreatic Beta Cells
- 30 October 2009
- Published by Springer Nature
- p. 85-103
Cell Cycle Regulation in Human Pancreatic Beta Cells